Finance

Beta
Lists
4587:TYO
Peptidream Inc
Â¥1,019.00
+4.17%
(+40.80) 1D
Jun 18, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4587...
Open
Â¥996
High
Â¥1,035
Low
Â¥996
Mkt. cap
132.48B
Avg. vol.
1.05M
Volume
1.38M
52-wk high
Â¥1,818
52-wk low
Â¥916
EPS
-Â¥28
Shares outstanding
123.37M
No. of employees
645
Open
Â¥996
High
Â¥1,035
Low
Â¥996
Mkt. cap
132.48B
Avg. vol.
1.05M
Volume
1.38M
52-wk high
Â¥1,818
52-wk low
Â¥916
EPS
-Â¥28
Shares outstanding
123.37M
No. of employees
645
News stories
From sources across the web
About Peptidream Inc
CEO-
Employees645
FoundedJul 3, 2006
HeadquartersKawasaki, Kanagawa, Japan
SectorBiotechnology
Websitepeptidream.com
Last report
May 13, 2026
Fiscal period
Q1 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
4.76B / 4.54B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.31B
4.31B
5.66B
4.76B
Cost of goods sold
2.61B
2.64B
2.98B
2.74B
Cost of revenue
2.61B
2.64B
2.98B
2.74B
Research and development expenses
1.15B
1.16B
1.72B
1.23B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.81B
1.93B
1.44B
1.93B
Operating expense
2.96B
3.10B
3.59B
3.17B
Total operating expenses
5.57B
5.75B
6.56B
5.91B
Operating income
-1.26B
-1.43B
-899.88M
-1.14B
Other non operating income
1.00K
1.00K
-
3.00M
EBT including unusual items
-1.43B
-1.48B
-971.25M
-1.20B
EBT excluding unusual items
-1.43B
-1.48B
-917.25M
-1.20B
Income tax expense
-340.00M
-382.38M
-439.59M
-347.00M
Effective tax rate
23.80%
25.89%
45.26%
28.89%
Other operating expenses
-1.09M
4.35M
102.59M
8.00M
Net income
-1.09B
-1.09B
-531.66M
-854.00M
Net profit margin
-25.26%
-25.38%
-9.39%
-17.93%
Earnings per share
-
-
-
-
Interest and investment income
18.72M
49.79M
102.96M
94.00M
Interest expense
-168.70M
-74.98M
-
-155.00M
Net interest expenses
-149.98M
-25.19M
102.96M
-61.00M
Depreciation and amortization charges
-
-
324.00M
-
EBITDA
-734.40M
-913.87M
-367.66M
-600.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer